DOJs 68 Billion Enforcement Push Targets Nonprofit Fraud Reveals 250 Million Missing in Minnesota Nvidia Earnings in Focus Geopolitical Commentary Could Shape US Equities Billionaire Rotates from Cloud to AI Strategic Shift or Market Overreaction Hitachi Secures Contract for Signaling System on Mexican Railway Stephen Colberts Final Late Show Marks End of an Era for CBS LateNight Programming California Judge Orders Kars4Kids to Disclose Charity Affiliation or Pull Ads INCR Q2 2023 Earnings EPS Surges Past Estimates as Profitability Strengthens Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed UMBFO Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Amid Stable Trading PMCB Q1 2026 Earnings PreRevenue Biotech Reports Negative EPS Stock Rises on Potential Pipeline Progress REZI Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Stock Slides Blackbaud BLKB Q1 2026 Earnings Slight EPS Beat Drives Modest Share Gain Anterix Inc ATEX Holds Steady Near Key Support Levels HP Inc Shares Slip Amid Market Pressure Key Support Levels in Focus Invesco Pennsylvania Value Municipal Income Trust VPV Holds Steady Near Support Amid Low Volatility Uranium Energy Corp UEC Gains 376 as Nuclear Sentiment Strengthens John Wiley Sons WLY Edges Higher Modest Gains Amid Consolidation Phase Trump Approval Ratings Slip Below 39 in Four of Five Recent Polls PEG Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Algonquin Power Utilities Preferred Shares AQNB Edge Higher Amidst Steady BondLike Trading MARA Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises 34 FTLF Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty RPM Q1 2026 Earnings Strong EPS Beat Driven by Margin Expansion and Operational Efficiency Quantum Biopharma Ltd QNTM Q4 2025 Earnings Biotech Firm Reports Wider Loss Amid Lack of Revenue Visibility SMTI Q1 2026 Earnings Profitability Breakthrough Surpasses Estimates SCI Q1 2026 Earnings EPS Misses Estimates by 44 Shares Edge Higher CYTK Q1 2026 Earnings ClinicalStage Biotech Beats EPS Estimates but Stock Slips